Morgan Stanley Biomerica Inc Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Biomerica Inc stock. As of the latest transaction made, Morgan Stanley holds 565 shares of BMRA stock, worth $180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
565
Previous 580
2.59%
Holding current value
$180
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BMRA
# of Institutions
38Shares Held
2.4MCall Options Held
0Put Options Held
0-
Granahan Investment Management, LLC Waltham, MA860KShares$275,3450.02% of portfolio
-
Russell Investments Group, Ltd.226KShares$72,3580.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA215KShares$68,6890.0% of portfolio
-
Potomac Capital Management, Inc.168KShares$53,6640.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$47,7050.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $4.3M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...